Figure 6 | Scientific Reports

Figure 6

From: Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis

Figure 6

Immune infiltration, GSVA, GSEA analyses and prediction of chemotherapeutic response of the prognostic risk score model. (A,B) Immune cells expressed levels between high- and low-risk groups in TCGA (A) and CGGA (B). (C,D) The GSVA analysis in TCGA (C) and CGGA (D). (E,H) The GSEA analysis in TCGA. (I–L) Drug sensitivity of this risk score model, temozolomide, PD.0332991, IPA.3, and BMS.754807 as representatives. *p < 0.05; ****p < 0.0001.

Back to article page